GlassScriptPhysician profile
Steven Glickman
NPI 1730152141
$1,199.93
in general payments reported to CMS, 2019-2025
17 companies · $294 in 2025
The $294 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $364 · 2020: $212 · 2021: $46.95 · 2022: $144 · 2023: $76.29 · 2024: $62.09 · 2025: $294.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $433.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $432.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Wright Medical Technology, INC. | $423.59 | 2019-2020 | |
| Stryker Corporation | $201.11 | 2019-2025 | Cartiva Synthetic Cartilage Implant, Viaflow, Ortholoc 2 Lapifuse |
| Depuy Synthes Sales INC. | $133.26 | 2024-2025 | Dynacord, Foot Osteotomy Wedge System |
| Treace Medical Concepts, INC. | $63.60 | 2025 | |
| Paragon 28, INC. | $53.67 | 2025 | Mini Monster |
| Acera Surgical, INC. | $52.51 | 2019 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $38.61 | 2019-2022 | |
| Paratek Pharmaceuticals, INC. | $36.83 | 2025 | Nuzyra |
| Nevro Corp. | $34.43 | 2022 | |
| Horizon Therapeutics Plc | $32.93 | 2021 | |
| Convatec INC. | $31.03 | 2022 | |
| Organogenesis INC. | $19.01 | 2022 | |
| Reprise Biomedical, INC. | $18.73 | 2023 | Miro3d |
| Bioventus LLC | $16.43 | 2020 | |
| Carbofix Orthopedics INC | $14.96 | 2020 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $14.89 | 2024 | Proclaim |
| Vertex Pharmaceuticals Incorporated | $14.34 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Glickman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.